MAX Chat
Calendrier des promotions CervoMed Inc.
Calendrier avancé
Graphique simple
À propos de l'entreprise CervoMed Inc.
CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of drug treatments for neurodegenerative diseases. It develops neflamapimod, an orally administered small molecule brain penetrant for the treatment of dementia with Lewy bodies (DLB), Alzheimer's diseases, and brain stroke recovery. The company is based in Boston, Massachusetts.Paramètres de base
IPO date
2016-01-04
ISIN
US15713L1098
Industry
Biotechnology
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Сайт
Grade
Sous-estimation
| Nom | Signification | Grade |
| P/S | 1.98 | 7 |
| P/BV | 0.4922 | 10 |
| P/E | 0 | 0 |
Efficacité
| Nom | Signification | Grade |
| ROA | -61.41 | 0 |
| ROE | -69.95 | 0 |
| ROIC | 0 | 0 |
Dividendes
| Nom | Signification | Grade |
| Rendement en dividendes | 0 | 0 |
| DSI | 0 | 0 |
| Croissance moyenne du dividende | 0 | 0 |
Devoir
| Nom | Signification | Grade |
| Debt/EBITDA | 0 | 10 |
| Debt/Ratio | 0 | 10 |
| Debt/Equity | 0.099 | 10 |
Impulsion de croissance
| Nom | Signification | Grade |
| Rentabilité Revenue, % | 36.29 | 5 |
| Rentabilité Ebitda, % | 14.64 | 3 |
| Rentabilité EPS, % | -81.79 | 0 |
paper.price.prices
| Prix | Common.min. | Common.max. | Changement | paper.changes_in_industry | paper.changes_in_index | |
| common.calendar.number_days.1 | 7.12 $ | 0 $ | 0 $ | 0 % | 0 % | 0 % |
| common.calendar.number_days.7d | 7.47 $ | 0 $ | 0 $ | -4.69 % | 0 % | 0 % |
| common.calendar.number_days.30d | 8.47 $ | 0 $ | 0 $ | -15.94 % | 0 % | 0 % |
| common.calendar.number_days.90d | 8.5 $ | 7.12 $ | 10.56 $ | -16.19 % | 0 % | 0 % |
| common.calendar.number_days.180d | 2.21 $ | 2.12 $ | 14.29 $ | +222.17 % | 0 % | 0 % |
| common.calendar.number_days.1y | 16.29 $ | 1.9 $ | 18.62 $ | -56.29 % | 0 % | 0 % |
| common.calendar.number_days.3y | 7 $ | 1.9 $ | 25.93 $ | +1.71 % | 0 % | 0 % |
| common.calendar.number_days.5y | 1.5 $ | 0.1711 $ | 25.93 $ | +374.67 % | 0 % | 0 % |
| common.calendar.number_days.10y | 0.1711 $ | 0.1711 $ | 25.93 $ | +4 161.31 % | 0 % | 0 % |
| common.calendar.number_days.ytd | 2.31 $ | 2.04 $ | 14.29 $ | +208.23 % | 0 % | 0 % |
Principaux propriétaires
Entreprises similaires
P/E & P/BV
Gestion d'entreprise
| Superviseur | Titre d'emploi | Paiement | Année de naissance |
| Dr. Sylvie L. Gregoire Pharm.D. | Co-Founder & Director | 352.43k | 1961 (64 année) |
| Dr. John J. Alam M.D. | Co-Founder, CEO, President & Director | 680.25k | 1962 (63 année) |
| Dr. Robert J. Cobuzzi Jr., Ph.D. | COO & Director | 386.6k | 1965 (60 années) |
| Mr. William Robert Elder J.D. | CFO & General Counsel | 407.55k | 1983 (42 année) |
| Ms. Kelly Blackburn M.H.A. | Senior Vice President of Clinical Development | 404.94k | 1964 (61 année) |
Informations sur l'entreprise
Adresse: United States, Boston. MA, 20 Park Plaza - Ouvrir dans google maps, Ouvrir les cartes yandex
Site web: https://www.cervomed.com
Site web: https://www.cervomed.com
